DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rqjcc2/endstage_kidney) has announced the addition of the "End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015" report to their offering.
"End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015" provides data on the End-Stage Kidney Disease (end-stage renal disease or ESRD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on End-Stage Kidney Disease (end-stage renal disease or ESRD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating End-Stage Kidney Disease (end-stage renal disease or ESRD).
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Top Companies Participating in End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials
- Amgen Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- AstraZeneca PLC
- Pfizer Inc.
- Sanofi
- Shire Plc
- Merck & Co., Inc.
- Baxter International Inc.
- AbbVie Inc.
For more information visit http://www.researchandmarkets.com/research/rqjcc2/endstage_kidney
